Diagnostic Dose (Provocative Testing): In endocrinology practice, sermorelin (GHRH 1-29) can be used as a diagnostic agent to test pituitary GH reserve
Monitor for symptoms of hypotension and edema when amlodipine is coadministered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology ( 12.3)]
Factors such as chronic nutrient deprivation, hypoxia, insulin concentrations, growth hormone concentrations, and glucocorticoid concentrations are known to regulate IGFBP-1 and IGFBP-3 expression (Suwanichkul et al., 1994
Call at 0203 824 2840 to speak to a team member
The following are documented considerations from the research and safety literature, framed for research handling not medical advice and not an exhaustive list
Editorial refresh Practical 2026 note for Sermorelin vs GHK This update makes Sermorelin vs GHK more specific by tying BPC-157, sermorelin, ghk, which, better to the page's original clinical, cost, access, or comparison angle